Austar Lifesciences Limited
Research Austar Lifesciences Limited (6118.HK) on Bullrun: market cap HKD 348.56M, P/E 17.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6118.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 348.56M
- P/E17.0
- Financial periodFY2025
- RevenueCNY 1.53B
- Revenue growth2.0%
- Net incomeCNY 33.81M
- Free cash flowCNY 102.40M
- Gross margin19.2%
Valuation Snapshot
latest market cap is HKD 348.56M; P/E is 17.0.
Peer valuation comparison
Latest P/E is 17x versus a Healthcare sector median of 21.8x (22.0% below).
Latest P/E is 17x versus a China median of 16.28x (4.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 1.53B | CNY 33.81M | CNY 102.40M | 19.2% | 0.07 | CNY 227.39M | CNY 343.68M | CNY 822.55M |
| FY2024 | CNY 1.50B | CNY 16.08M | CNY 75.72M | 20.1% | 0.03 | CNY 166.81M | CNY 401.95M | CNY 791.41M |
| FY2023 | CNY 1.76B | -CNY 113.47M | -CNY 133.59M | 19.1% | -0.22 | CNY 163.77M | CNY 496.20M | CNY 773.01M |
| FY2022 | CNY 2.16B | CNY 87.46M | -CNY 174.37M | 22.7% | 0.17 | CNY 133.62M | CNY 336.55M | CNY 896.94M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 348.56M | 17.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Austar Lifesciences Limited
Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. The company also offers clean utility equipment and chemical pharmaceutical preparation systems; bioprocess equipment and systems;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Austar Lifesciences Limited's market cap?
Austar Lifesciences Limited's market capitalization is HKD 348.56M.
What is Austar Lifesciences Limited's P/E ratio?
Austar Lifesciences Limited's price-to-earnings (P/E) ratio is 17.0.
What does Austar Lifesciences Limited do?
Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments.